Physera

About Physera

Physera, founded in 2015 by Dan Rubinstein and Cameron Marlow, developed a digital platform for delivering musculoskeletal (MSK) care. The company's primary offering was a mobile application that connected patients with licensed physical therapists for virtual consultations, diagnosis, and personalized exercise programs. This telehealth service was designed to address the high costs and accessibility issues associated with traditional physical therapy, targeting a U.S. market where annual spending on MSK conditions exceeds $200 billion.

The founders' backgrounds were instrumental in shaping the company's data-driven approach. CEO Dan Rubinstein, who holds a Ph.D. in Statistics from Stanford, previously held product leadership roles at Facebook, Google, and Palantir, and was an Entrepreneur in Residence at Khosla Ventures. His interest in healthcare was fueled by a desire to apply the predictive and closed-loop modeling used by tech giants to improve patient outcomes. CTO Cameron Marlow, who also worked at Facebook as Head of Data Science and holds a Ph.D. from MIT Media Lab, brought deep expertise in data science and technology. Together, they aimed to make evidence-based care more convenient and effective.

Physera’s business model served employers, health plans, and direct-to-consumer channels. For employers, the value proposition was reducing healthcare spending by preempting unnecessary surgeries, imaging, and opioid prescriptions. The platform's features included video access to physical therapists, in-app animations, voice prompts for exercises, and progress monitoring to improve patient adherence. A significant milestone for Physera was its acquisition by Omada Health in May 2020 for a reported $30 million. The acquisition integrated Physera's MSK solution into Omada's broader digital care suite, which already addressed chronic conditions like diabetes and hypertension, creating a more comprehensive virtual care offering.